| Download the amazing global Makindo app: Android | Apple | |
|---|---|
| MEDICAL DISCLAIMER: Educational use only. Not for diagnosis or management. See below for full disclaimer. |
⚠️ Early diagnosis of Anthrax and the prompt initiation of combination antimicrobial therapy are critical for survival. 💨 Inhalational anthrax, in particular, carries a high mortality if untreated and requires immediate critical care involvement.
| Scenario | Drug & Dose |
|---|---|
| 🖐️ Cutaneous Anthrax (mild, non-systemic) |
Ciprofloxacin 500 mg PO BD (7–10 days)
OR
Doxycycline 100 mg PO BD (7–10 days)
💡 If systemic features → use IV + combination therapy. |
| 💨 Inhalational Anthrax / Systemic infection |
Ciprofloxacin 400 mg IV every 12h
OR
Doxycycline 100 mg IV every 12h
➕ Add 1–2 additional agents (rifampicin, clindamycin, or aminoglycoside) for synergy. Duration: ≥60 days (due to persistent spores). |
| 🧠 Anthrax meningitis (suspected/confirmed) | Ciprofloxacin IV (as above) ➕ Rifampicin IV ➕ Clindamycin IV (Triple therapy recommended). |
| 🧴 Post-exposure prophylaxis (PEP) |
Ciprofloxacin 500 mg PO BD for 60 days
OR
Doxycycline 100 mg PO BD for 60 days.
➕ Anthrax vaccine where available. |